Use of ritonabiru (ABT538) in order to improve the medicine movement of the medicine which is renewed by the cytochrome P450 in the method of dealing with the AIDS

摘要

There is described a combination of ritonavir or a pharmaceutically acceptable salt thereof in combination with another HIV protease inhibitor, formulated as a single or separate composition, for use in the inhibition or treatment of an HIV infection or AIDS in a human host.